VERQUVO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Vericiguat.
Product ID | 0006-5030_15049ae3-29b9-496a-bf12-350978af10bb |
NDC | 0006-5030 |
Product Type | Human Prescription Drug |
Proprietary Name | VERQUVO |
Generic Name | Vericiguat |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2021-02-01 |
Marketing Category | NDA / NDA |
Application Number | NDA214377 |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | VERICIGUAT |
Active Ingredient Strength | 10 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-02-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0006-5028 | VERQUVO | vericiguat |
0006-5029 | VERQUVO | vericiguat |
0006-5030 | VERQUVO | vericiguat |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VERQUVO 90764015 not registered Live/Pending |
Bayer Aktiengesellschaft 2021-06-09 |
VERQUVO 87952816 5810492 Live/Registered |
Bayer Aktiengesellschaft 2018-06-07 |